All Updates

The American Cancer Society Cancer Action Network (ACS CAN) was disappointed to see the legislature overturn the governor’s veto of legislation that will limit access to Medicaid.

Earlier this week, the New Jersey State Assembly voted to advance a bill that seeks to create more stability for patients. The proposal (Assembly Bill 5217) would curb an unfair insurance practice that makes critical medication more expensive and access unpredictable. With its passage in committee, advocates with the American Cancer Society Cancer Action Network (ACS CAN) are hopeful that the full Senate and Governor Murphy see the bill’s momentum as a call to action to take the final steps to pass and enact the necessary reforms.

Today, the U.S. Department of Health and Human Services (HHS) announced it will be cutting more than 10,000 jobs as part of a major restructuring that will impact operations at the U.S. Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS), among other critical agencies.

Today, the U.S. Department of Health and Human Services (HHS) announced it will be cutting more than 10,000 jobs as part of a major restructuring that will impact operations at the U.S. Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS), among other critical agencies.

La Cámara de Representantes de EE. UU. presentó una legislación que reautorizaría el Programa Nacional de Detección Temprana de Cáncer de Mama y Cuello Uterino (NBCCEDP, por sus siglas en inglés) para los años fiscales comprendidos entre 2026 y 2030.

Yesterday, the U.S. Senate voted to confirm Jay Bhattacharya, MD, PhD, as the new director of the National Institutes of Health (NIH).

Yesterday, the U.S. Senate voted to confirm Dr. Marty Makary as the next commissioner of the Food and Drug Administration (FDA).

La Cámara de Representantes de EE. UU. presentó una legislación que reautorizaría el Programa Nacional de Detección Temprana de Cáncer de Mama y Cuello Uterino (NBCCEDP, por sus siglas en inglés) para los años fiscales comprendidos entre 2026 y 2030.

Yesterday, both chambers in the New Jersey State Legislature passed legislation (Assembly Bill 4163 / Senate Bill 3098) to increase access to biomarker testing, which can help determine the best treatment plan for each patient. The bill will now go to Governor Murphy’s desk, providing him the opportunity to ensure coverage of this essential testing for more New Jerseyans. The American Cancer Society Cancer Action Network (ACS CAN) is leading the efforts on this significant policy change to ensure more patients can get the testing needed to access precision medicine.